ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

塩酸 パパベリン

Papaverine hydrochloride

HCID 657373
ノート反応

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
61-25-6
標準SMILES
COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC.[Cl-].[H+]
InChIKey
UOTMYNBWXDUBNX-UHFFFAOYSA-N
分子式
C20H22ClNO4
平均分子量
375.85 g/mol

名称と識別子

優先名称
Papaverine hydrochloride
現地名
塩酸 パパベリン
英語名
Papaverine hydrochloride
分子式
C20H22ClNO4
分子量
375.85

名称と別名

塩酸 パパベリンパパベリン塩酸塩塩パパ1-[(3,4-ジメトキシフェニル)メチル]-6,7-ジメトキシイソキノリン·塩酸塩パパベリン·塩酸塩塩酸パパベリン6,7-ジメトキシ-1-(3,4-ジメトキシベンジル)イソキノリン塩酸塩パパベリン 塩酸塩パパベリン塩酸塩, 99%パパベリン塩酸塩 (JP17)PAPAVERINE HCLpaph
名称をさらに表示
dipavBOC-azide1-(3,4-DIMETHOXYBENZYL)-6,7-DIMETHOXYISOQUINOLINE HYDROCHLORIDElapavvasaldynovasoptenylpameion

データベース識別子

CAS
61-25-6
PubChem CID
657373

物性

物理化学的性質

融点
226 °C · 226°C (dec.)
貯蔵温度
Amber Vial, Refrigerator
溶解性
2 O: · H2O: 25 mg/mL
外見
粉
色
白い
PH
pH (20g/l, 25℃) : 3.0~4.0
水溶解度
溶けやすい
Merck
14 · 14,7019
BRN
3921435 · 3921435
安定性
安定していますが、光に敏感な場合があります。
InChI
InChI=1S/C20H21NO4.ClH/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16;/h5-8,10-12H,9H2,1-4H3;1H
InChIKey
UOTMYNBWXDUBNX-UHFFFAOYSA-N
SMILES
C1(CC2=CC=C(OC)C(OC)=C2)=C2C(C=C(OC)C(OC)=C2)=CC=N1.[H]Cl
CAS データベース
61 · 61-25-6(CAS DataBase Reference)
EPAの化学物質情報
Papaverine hydrochloride (61-25-6)

化学的性質

化学的特性PAPAVERINE HYDROCHLORIDE is Crystalline Solid

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

安全データ

F
8
wgk
1
tsca
TSCA listed
rtecs
NW8575000
ridadr
UN 1544 6.1/PG 3
毒性
LD50 in mice, rats (mg/kg): 27.5, 20 i.v.; 150, 370 s.c. (Levis)
hs_code
29391900
risk_code
22-34-11
化審法
(5)-827
hazard_code
Xn,C,F
safety_code
22-45-36/37/39-26-16
hazard_class
6.1
packing_group
III
Hazard Classifications
Acute Tox. 3 Oral
ストレージクラス
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
危険度評価(NFPA 704基準/消防庁データ)
人的[青]=2

化学と産業

応用分野 · 6 件

用途ホスホジエステラーゼ阻害作 用を示します。

用途ホスホジエステラーゼ阻害作 用を示します。

説明Papaverine Hydrochloride, USP, is the hydrochloride of an alkaloid obtained from opium or prepared synthetically. It belongs to the benzylisoquinoline group of alkaloids. It does not contain a phenanthrene group as do morphine and codeine.Papaverine Hydrochloride, USP, is 6,7-dimethoxy-1-veratrylisoquinoline hydrochloride and contains, on the dried basis, not less than 98.5% of CHNO.HCI. The molecular weight is 375.85. The structural formula is as shown.Papaverine Hydrochloride occurs as white crystals or white crystalline powder. One gram dissolves in about 30 mL of water and in 120 mL of alcohol. It is soluble in chloroform and practically insoluble in ether.Papaverine Hydrochloride Injection, USP, is a clear, colorless to pale-yellow solution.Papaverine Hydrochloride, for parenteral administration, is a smooth-muscle relaxant that is available in vials containing 30 mg/mL. Each vial also contains edetate disodium 0.005%. The 10 mL vials also contain chlorobutanol 0.5% as a preservative. pH may be adjusted with sodium citrate and/or citric acid.

来歴Human beings have a long history of using opium poppy as food and narcotics, which can be dated back to the Neolithic age. The opium, which is the dried product of the opium poppy juice, is widely used as analgesics in the old and new civilizations of the old continent except the Chinese civilization. In 1848, German chemist Georg Merck successfully isolated a new alkaloid from the opium liquor for the first time and named it as “papaverine” . He also determined the correct molecular formula of papaverine as C20 H21NO4 and prepared the papaverine hydrochloride and nitrate by recrystallization method. Then, Goldschmiedt etal. put forward the molecular structure of papaverine by studying its oxidation products in 1883 and determined the isoquinoline ring as the core structure of papaverine in 1888 . Since the content of papaverine in plants is very low (less than 1%) and can hardly meet the clinical needs, so Pictet and Gams proposed a synthetic method of papaverine in 1909, which makes the large-scale industrialized production of papaverine possible . Study on the pharmacology of papaverine was first published in 1914 by Professor Pal of Vienna, who found that papaverine possessed smooth muscle relaxation effect without causing smooth muscle paralysis and can be used for the treatment of hypertension, angina, and acute uremia .

使用Papaverine hydrochloride is as effective as sodium diclofenac for the short-term relief of acute renal colic pain and may be advantageous in patients with contraindications for nonsteroidal anti-inflammatory drugs. However, sodium diclofenac appears to provide a longer effective analgesia.Papaverine hydrochloride belongs to the group of benzylisoquinoline alkaloid. It is obtained from opium poppy.Papaverine hydrochloride has been used:in oxygenated Krebs solution for tissue mechanics analysisas a vasodilator in heparinized horse serum in tissue uptake techniqueas an inhibitor of H-MPP+ uptake into stably transfected 293 cells expressing either extraneuronal monoamine transporter (EMT) human or EMT rat

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

一般的な説明Papaverine hydrochloride,6,7-dimethoxy-1-veratrylisoquinoline hydrochloride,was isolated by Merck in 1848 from opium,in which it occurs to the extent of about 1%. Althoughits natural origin is closely related to morphine, the pharmacologicalactions of papaverine hydrochloride areunlike those of morphine. Its main effect is as a spasmolyticon smooth muscle, acting as a direct, nonspecificrelaxant on vascular, cardiac, and other smooth muscle.Because of its broad antispasmodic action on ACh muscarinicreceptors, it is often called a nonspecific antagonist.Papaverine hydrochloride has been used in the treatmentof peripheral vascular disorders, but its use is limitedby lack of potency. Papaverine hydrochloride interferes with the mechanismof muscle contraction by inhibiting the cyclic nucleotidephosphodiesterases in smooth muscle cells responsible forconverting cAMP and cyclic guanosine monophosphate(cGMP) to 5' -AMP and 5' -GMP, respectively. The increasedlevels of cAMP and cGMP are associated with muscle relaxation through their phosphorylation of myosinlight-chain kinase.

調製方法 · 1 件

純化方法Recrystallise it from H2O. It sublimes at 140o/0.1mm. Its solubility in H2O is 5%. [Saunders & Srivastava J Pharm Pharmacol 3 78 1951, Biggs Trans Faraday Soc 50 800 1954.] The free base has m 148-150o, The picrate has m 186-189o(dec, 186-186.5o(dec) [Bobbitt J Org Chem 22 1729 1957]. [Beilstein 21 II 202, 21 III/IV 2788, 21/6 V 182.]

上流・下流製品情報

上流原料

N-(3,4-ジメトキシフェネチル)-3,4-ジメトキシベンゼンアセトアミド1-(3,4-dimethoxybenzyl)-3,4-dihydro-6,7-dimethoxyisoquinolinium chloride1-(3,4-ジメトキシベンジル)-6,7-ジメトキシ-3,4-ジヒドロイソキノリンホモベラトル酸パパベリンホモベラトリルアミン

サプライヤー100 社

艾吉析科技(上海)有限公司17717235263 · [email protected]
合肥翰刚医药科技有限公司+8618062405514 · [email protected]
咸宁深蓝生物医药研发有限公司18171815831 · [email protected]
湖南嘉航医药科技有限公司85521272 18229978283 · [email protected]
陕西缔都化学有限公司029-029-81123119 17391733320 · [email protected]
江苏艾康生物医药研发有限公司025-025-66113011 15955137747 · [email protected]
武汉众志诚生物技术有限公司13628624121 13628604890 · [email protected]
广州隽唐科技有限公司020-36607679 13502246435 · [email protected]
Jai Radhe Sales+(91)-(79)-26431096/65255722 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
湖北丹鼎医药科技有限公司18917019315(微信同号) 17701422019 · [email protected]
上海迈瑞尔生化科技有限公司4006356688 18621169109 · [email protected]
阿法埃莎(中国)化学有限公司400-6106006 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
梯希爱(上海)化工贸易有限公司021-61109150 · [email protected]
欧利希(湖北)医药科技有限公司17316404525 17316404525 · [email protected]
上海钰康生物科技有限公司18939844854 · [email protected]
Protheragen-ING+86-15618352007 · [email protected]
Hubei Danding Pharmaceutical Technology Co., Ltd+86-18917019315 +86-13173601896 · [email protected]
广州济成进出口贸易有限公司13682223272 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
佛山宝诺生物科技有限公司0757-85921206 18520245316 · [email protected]
贵州迪大科技有限责任公司0851-8475-2296 18096062265 · [email protected]
斯百全化学(上海)有限公司021-021-021-67601398-809-809-809 15221380277 · [email protected]
赛默飞世尔科技(中国)有限公司800-810-5118 · [email protected]
北京伊诺凯科技有限公司400-810-7969 010-59572699 · [email protected]
TCI AMERICA800-4238616 · [email protected]
TOKYO CHEMICAL INDUSTRY CO., LTD.03-36680489 · [email protected]
TCI Europe320-37350700 · [email protected]
成都思天德生物科技有限公司028-83243028 19136088901 · [email protected]
南京生利德生物科技有限公司025-57798810 18652991625 · [email protected]
南京世洲生物科技有限公司13675144456 · [email protected]
陕西缔都医药化工有限公司+86-29-87569262 +86-15003564040 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
武汉贝乐叶生物医药科技有限公司18086118078 · [email protected]
池州凯隆进出口贸易有限公司[email protected]
Sigma-Aldrich西格玛奥德里奇(上海)贸易有限公司021-61415566 800-8193336 · [email protected]
AN PharmaTech Co Ltd86(21)68097365 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
上海皓之翔生物科技有限公司(原上海拓青化工有限公司)526763801 13301653310 · [email protected]
九鼎化学(上海)科技有限公司4009209199 · [email protected]
广州维奥康药业科技有限公司+86-13424074264; 13726739909 · [email protected]
艾吉析科技(上海)有限公司17717235263 17717235263 · [email protected]
上海阿拉丁生化科技股份有限公司6206333 13167063860 · [email protected]
青海制药厂有限公司0971-5506700 · [email protected]、[email protected]
武汉多普乐生物医药有限公司+86-02787215551 19945035818 · [email protected]
四川普西奥标物科技有限公司13540909846 13882008651 · [email protected]
南京熙朗化工产品有限公司18936048580 · [email protected]
山东盛之源生物科技有限公司13969162569 · [email protected]
上海炎泽化工有限公司15345144255 19901447308 · [email protected]